Regulatory Ramblings: Episode 75 - Rethinking Hong Kong’s Startup Ecosystem and Its Legal Foundations with Syed Musheer Ahmed, Joshua Chu, and David Cameron
Sunday Book Review: August 3, 2025, The Books from the EthicsVerse Library Edition
Fox on Podcasting: PodPage and Beyond: Elevating Listener Experience with Dave Jackson
What’s in Your Operating Agreement? Legal Tips for Healthcare Providers
Money-Saving Licensing Tips for Startups
Sunday Book Review: July 27, 2025, The Best Books on Economics Edition
Innovation in Compliance: The Power of Accountability and Team Culture with Gina Cotner
Compliance Tip of the Day: Rethinking Corporate AI Governance Through Design Intelligence
Daily Compliance News: July 21, 2025, The More Reasons Not to Go to China Edition
Sunday Book Review: July 20, 2025, The Best Books on Business Edition
Tips for Conducting a Trade Secret Assessment with Rob Jensen
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 242: Business Planning in Healthcare & Life Sciences with Jennifer McEwen of Maynard Nexsen
Daily Compliance News: July 14, 2025, The Secret Business Sauce-Reading Edition
Sunday Book Review: July 13, 2025, The Best Books on History Edition
Treating Compliance Like an Asset
Essential Steps to Sell Your Business
Regulatory Ramblings: Episode 72 - Cultural Roots, Belonging, and the Fear of Change: What’s Next for Inclusion?
Innovation in Compliance: LeadHERship with Linda Fisk
The Future of Supply Chains: Chris Andrassy on Using AI to Predict & Prevent Disruptions
Compliance Amidst a Global Consensus Breakdown
“Family offices are continuing to actively allocate substantial funds to real estate as a core component of their overall investment strategy. There is continued preference for multi-family and industrial projects and...more
To help businesses, investors, and deal professionals better understand the evolving independent sponsor landscape, Robert Connolly – a partner in LP’s Corporate Practice Group and leader of LP’s Independent Sponsor team –...more
Over the past few years, we have been deeply engaged in – and have closely observed – the rapid growth of Chinese biotech companies. Despite a challenging market environment, these companies have continued to make remarkable...more
Business development companies (“BDCs”) were created by Congress in 1980 to serve as closed-end, venture capital funds for retail investors by financing small to mid-sized U.S. private companies. Since about 2004, BDC...more
Private Equity (PE) firms face pressure to deliver strong returns while managing downside risk. This necessitates a focus on performance metrics that measure value creation and overall health. However, the reporting shared by...more